Furthermore, after treatment with a compound that sensitized chemoresistant CRC cells to anti-cancer drugs, it was observed that the overexpressed ABC transporters such as ABCA5 were downregulated [49]. The gene discussed is ABCG2; the disease is colorectal carcinoma.